These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2878723)

  • 21. Comparative effects of d-sotalol and l-sotalol on the atrioventricular node of the rabbit heart.
    Beyer T; Brachmann J; Kübler W
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):240-6. PubMed ID: 7692164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.
    Kato R; Ikeda N; Yabek SM; Kannan R; Singh BN
    J Am Coll Cardiol; 1986 Jan; 7(1):116-25. PubMed ID: 3941198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Circulation; 1983 Oct; 68(4):865-71. PubMed ID: 6616781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concentration dependence of class III and beta-adrenergic blocking effects of sotalol in anesthetized dogs.
    Nattel S; Feder-Elituv R; Matthews C; Nayebpour M; Talajic M
    J Am Coll Cardiol; 1989 Apr; 13(5):1190-4. PubMed ID: 2564401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new beta-adrenergic antagonists.
    Chung DC; Laschuk MJ
    Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the effects of chronic oral therapy with atenolol and sotalol on ventricular monophasic action potential duration and effective refractory period.
    Way BP; Forfar JC; Cobbe SM
    Am Heart J; 1988 Sep; 116(3):740-6. PubMed ID: 3046277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C; Drolet B; Hamelin BA; Turgeon J
    J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.
    Funck-Brentano C
    Eur Heart J; 1993 Nov; 14 Suppl H():30-5. PubMed ID: 7904936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiologic properties of sotalol and d-sotalol. A current view.
    Touboul P
    Eur Heart J; 1993 Nov; 14 Suppl H():24-9. PubMed ID: 7904935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sotalol, aprindine and their combination on maximum upstroke velocity of action potential in guinea-pig papillary muscle.
    Stroobandt R; Kesteloot H
    Eur J Pharmacol; 1986 Nov; 131(2-3):249-56. PubMed ID: 3816955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inotropic and haemodynamic effects of d- and d,l-sotalol: comparison with other antiarrhythmics.
    Seipel L; Hoffmeister HM
    Eur Heart J; 1993 Nov; 14 Suppl H():36-40. PubMed ID: 7904937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological characterization of the class III activity of sotalol and its enantiomers. New interpretation of use-dependent effects.
    Hafner D; Berger F; Borchard U; Kullmann A; Scherlitz A
    Arzneimittelforschung; 1988 Feb; 38(2):231-6. PubMed ID: 3370070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGIS-7229, the new combined class III antiarrhythmic agent: lack of EAD inducing effect.
    Bányász T; Magyar J; Varró A; Kovács A; Gyönös I; Szénási G; Nánási PP
    Gen Pharmacol; 1999 Mar; 32(3):329-33. PubMed ID: 10211587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 37. Chronopharmacokinetics of beta-receptor blocking drugs of different lipophilicity (propranolol, metoprolol, sotalol, atenolol) in plasma and tissues after single and multiple dosing in the rat.
    Lemmer B; Winkler H; Ohm T; Fink M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):42-9. PubMed ID: 2864639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic effects of d-sotalol in humans.
    McComb JM; McGovern B; McGowan JB; Ruskin JN; Garan H
    J Am Coll Cardiol; 1987 Jul; 10(1):211-7. PubMed ID: 3597990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs.
    Patel BR; Kirschbaum JJ; Poet RB
    J Pharm Sci; 1981 Mar; 70(3):336-8. PubMed ID: 6115047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.